Suppliers / Alivira Animal Health

Alivira Animal Health

India Updated 9 July 2026

Alivira Animal Health is an API and finished-dose manufacturer based in India. It holds 2 active US drug master files and 11 valid CEPs across a filed portfolio of 12 molecules. Its filings concentrate with FDA (GH), Health Canada and ZAMRA (ZM). Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 22 September 2023 as VAI. Customs aggregates show $9.4M of exports covering 341 molecules to 49 destinations in 2025.

2
active US DMFs
11
valid CEPs
3
registered plants 1 with an FDA FEI number
33
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 22 September 2023 VAI US FDA
  • 30 March 2018 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Visakhapatnam, India 3011747378
Gidc, India Not on file
tal khambhatkansari 388 630anand, India Not on file

What they file, and where

Molecule Regulators Docs
Triclabendazole For Veterinary Use EDQM 2
Albendazole US FDA 1
Carprofen For Veterinary Use EDQM 1
Diclazuril For Veterinary Use EDQM 1
Febantel For Veterinary Use EDQM 1
Fenbendazole For Veterinary Use EDQM 1
Flubendazole EDQM 1
Flunixin Meglumine For Veterinary Use EDQM 1
Lufenuron For Veterinary Use EDQM 1
Oxfendazole For Veterinary Use EDQM 1
Show all 12 molecules on file
Triclabendazole US FDA 1
Xylazine Hydrochloride For Veterinary Use EDQM 1

Also appears on these molecule pages

Albendazole API Flunixin Meglumine For Veterinary Use API Oxytetracycline finished dose

Filings and GMP by regulator

Regulator Filings GMP certificates
FDA (GH) 27 None
Health Canada 4 None
ZAMRA (ZM) 2 None
CDSCO (India) None 2
US FDA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $1.5M 9
2025 Not reported $9.4M 49
2024 Not reported $5.4M 42
2023 Not reported $7.6M 48

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Alivira Animal Health

Does Alivira Animal Health hold a US DMF or a CEP?
Alivira Animal Health holds 2 active US drug master files and 11 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Alivira Animal Health FDA-registered?
One site operated by Alivira Animal Health carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Alivira Animal Health's last inspection go?
The most recent inspection on record closed on 22 September 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 2 inspections are on file.
Where does Alivira Animal Health manufacture?
3 registered sites are on record, in India (Visakhapatnam, Gidc and Tal Khambhatkansari 388 630anand). Every site is listed on this page with the register it came from.
What does Alivira Animal Health make?
12 molecules are on record against Alivira Animal Health, including Triclabendazole For Veterinary Use, Albendazole, Carprofen For Veterinary Use and Diclazuril For Veterinary Use. Each links through to that molecule's full manufacturer list.
Which regulators recognise Alivira Animal Health's GMP?
Current GMP certificates are on record from CDSCO (India) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Alivira Animal Health comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 22 September 2023.

Comparable suppliers

Sequent Scientific shares 2 molecules Cipla shares 1 molecule Zydus Lifesciences shares 1 molecule Solara Active Pharma Sciences shares 1 molecule Unimark Remedies shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts